Oncogene - Table of Contents alert Volume 32 Issue 40

Advertisement Finally! Antibodies you can TRUST. Partnering with epigenetics experts including the BLUEPRINT Epigenome consortium, Diagenode has developed the absolute best epigenetics antibodies with the highest specificity and sensitivity available. Achieve unparalleled MeDIP, ChIP, and ChIP-seq results with validated antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 32, Issue 40 (October 2013) In this issue Review Original Articles Short Communication Also new AOP Advertisement   Genetically modified mouse models of cancer Topic Editors: Amancio Carnero and David Cano ¦ Submission deadline: 01 Apr 2014 This Research Topic from Frontiers in Oncology highlights how modelling cancer in mice provides important insights about tumor physiology in complicated and dynamic biological systems.  Find out more about how you can contribute to this RT or even host your own Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Communications is ranked #3 in the Multidisciplinary Sciences with an Impact Factor of 10.015* Your research. Our reach. Together we make an impact.  nature.com/naturecommunications  *2012 Journal Citation Reports® (Thomson Reuters, 2013) Review Top The cancer biology of whole-chromosome instability P H G Duijf and R Benezra Oncogene 2013 32: 4727-4736; advance online publication, January 14, 2013; 10.1038/onc.2012.616 Abstract | Full Text Original Articles Top WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function S Pandolfi, V Montagnani, J Y Penachioni, M C Vinci, B Olivito, L Borgognoni and B Stecca Oncogene 2013 32: 4737-4747; advance online publication, November 12, 2012; 10.1038/onc.2012.502 Abstract | Full Text BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery J Hagenbuchner, A V Kuznetsov, P Obexer and M J Ausserlechner Oncogene 2013 32: 4748-4757; advance online publication, November 12, 2012; 10.1038/onc.2012.500 Abstract | Full Text PIR2/Rnf144B regulates epithelial homeostasis by mediating degradation of p21WAF1 and p63 F Conforti, Ai Li Yang, M Cristina Piro, M Mellone, A Terrinoni, E Candi, P Tucci, G J Thomas, R A Knight, G Melino and B S Sayan Oncogene 2013 32: 4758-4765; advance online publication, November 5, 2012; 10.1038/onc.2012.497 Abstract | Full Text Ableson kinases negatively regulate invadopodia function and invasion in head and neck squamous cell carcinoma by inhibiting an HB-EGF autocrine loop K E Hayes, E L Walk, A G Ammer, L C Kelley, K H Martin and S A Weed Oncogene 2013 32: 4766-4777; advance online publication, November 12, 2012; 10.1038/onc.2012.513 Abstract | Full Text The CDK1 inhibitory kinase MYT1 in DNA damage checkpoint recovery J P H Chow and R Y C Poon Oncogene 2013 32: 4778-4788; advance online publication, November 12, 2012; 10.1038/onc.2012.504 Abstract | Full Text RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine P O Saunders, J Weiss, R Welschinger, R Baraz, K F Bradstock and L J Bendall Oncogene 2013 32: 4789-4797; advance online publication, November 5, 2012; 10.1038/onc.2012.498 Abstract | Full Text Loss of pRB and p107 disrupts cartilage development and promotes enchondroma formation A S Landman, P S Danielian and J A Lees Oncogene 2013 32: 4798-4805; advance online publication, November 12, 2012; 10.1038/onc.2012.496 Abstract | Full Text Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression A Pagliuca, C Valvo, E Fabrizi, S di Martino, M Biffoni, D Runci, S Forte, R De Maria and L Ricci-Vitiani Oncogene 2013 32: 4806-4813; advance online publication, November 5, 2012; 10.1038/onc.2012.495 Abstract | Full Text Mitochondrial dynamics regulates migration and invasion of breast cancer cells J Zhao, J Zhang, M Yu, Y Xie, Y Huang, D W Wolff, P W Abel and Y Tu Oncogene 2013 32: 4814-4824; advance online publication, November 5, 2012; 10.1038/onc.2012.494 Abstract | Full Text Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity A Arlt, S Sebens, S Krebs, C Geismann, M Grossmann, M-L Kruse, S Schreiber and H Schäfer Oncogene 2013 32: 4825-4835; advance online publication, October 29, 2012; 10.1038/onc.2012.493 Abstract | Full Text Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma E Monaghan-Benson and K Burridge Oncogene 2013 32: 4836-4844; advance online publication, December 3, 2012; 10.1038/onc.2012.492 Abstract | Full Text DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia S Lin, L Tian, H Shen, Y Gu, J-L Li, Z Chen, X Sun, M James You and L Wu Oncogene 2013 32: 4845-4853; advance online publication, October 29, 2012; 10.1038/onc.2012.482 Abstract | Full Text Short Communication Top A tumor suppressor role for srGAP3 in mammary epithelial cells A Lahoz and A Hall Oncogene 2013 32: 4854-4860; advance online publication, October 29, 2012; 10.1038/onc.2012.489 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.